期刊文献+

Survivin小分子抑制剂的研究进展 被引量:5

Advance in small-molecule inhibitors of Survivin
原文传递
导出
摘要 Survivin是凋亡抑制蛋白家族的一员,在抑制细胞凋亡、调控细胞周期、参与血管形成等方面发挥重要的生物学功能。Survivin在多种肿瘤组织中过量表达,与肿瘤不良预后和耐药性密切相关。Survivin作为一种潜在的肿瘤治疗靶点,其小分子抑制剂用于肿瘤治疗的研究为人们所关注。概述了Survivin的结构、功能及其在肿瘤组织中的特异性表达,综述了目前靶向Survivin的小分子抑制剂的研究进展。 Survivin is a member of inhibitor of apoptosis protein (IAP) family. It plays a critical biological role in many aspects including inhibiting apoptosis, regulating cell cycle and angiogenesis. Overexpression of Survivin exists in a variety of tumors, which is associated with the poor prognosis and drug resistance. As a potential target for cancer treatment, the small-molecule inhibitors of Survivin is becoming the hot point. This review provides a brief overview about Survivin structure, function, distribution in tumor, and a summary of the current progress of small-molecule inhibitors targeting Survivin.
出处 《生命科学》 CSCD 2014年第11期1207-1214,共8页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金项目(81372385) 国家高技术发展计划项目(2012AA02A503 2012AA020206)
关键词 SURVIVIN 抑制剂 肿瘤 Survivin inhibitor tumor
  • 相关文献

参考文献1

二级参考文献1

共引文献29

同被引文献41

  • 1Weiguo Cao,Weiping Yang,Rong Fan,Hao Li,Jinsong Jiang,Mei Geng,Yening Jin,Yunlin Wu.miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway[J]. Tumor Biology . 2014 (2)
  • 2Haien Zhao,Baoan Ma,Yucai Wang,Tao Han,Lianhe Zheng,Cong Sun,Tao Liu,Yinglong Zhang,Xiuchun Qiu,Qingyu Fan.??miR-34a inhibits the metastasis of osteosarcoma cells by repressingthe expression of CD44(J)Oncology Reports . 2013 (3)
  • 3Zhisen Shen,Guowen Zhan,Dong Ye,Yuan Ren,Lixin Cheng,Zhenhua Wu,Junming Guo.??MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin(J)Medical Oncology . 2012 (4)
  • 4Wen-Bo Li,Min-Wang Ma,Li-Jie Dong,Fei Wang,Lu-Xia Chen,Xiao-Rong Li.??MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme(J)Cancer Biology & Therapy . 2011 (6)
  • 5Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy(J)European Archives of Oto-Rhino-Laryngology . 2004 (7)
  • 6Tutar Y.Editorial:'mi RNA and Cancer;Computational and Experimental Approaches'. Current Pharmaceutical Biotechnology . 2014
  • 7Emiro Caicedo-Granados,Daniel M. Beswick,Apostolos Christopoulos,Diana E. Cunningham,Ali Razfar,James P. Ohr,Dwight E. Heron,Robert L. Ferris.Oncologic and Functional Outcomes of Partial Laryngeal Surgery for Intermediate-Stage Laryngeal Cancer. Otolaryngology -- Head and Neck Surgery . 2012
  • 8Rothschild SI.microR NA therapies in cancer. Mol Cell Ther . 2014
  • 9Geng D,Song X,Ning F,et al.Mi R-34a Inhibits Viability and Invasion of Human Papillomavirus-Positive Cervical Cancer Cells by Targeting E2F3 and Regulating Survivin. International Journal of Gynecological Cancer . 2015
  • 10Li XJ,Ren ZJ,Tang JH.MicroRNA-34a:a potential therapeutic target in human cancer. Cell Death Dis . 2014

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部